Ed Penhoet, Co-Founder of Chiron Corp.
He was president and CEO of the prominent biotechnology company until
May 1998. He has held leadership positions in the biotechnology
industry and in academia, and is currently vice chair of the
state-appointed board overseeing California's $3 billion stem cell
Hollings C. Renton, Chairman, President and CEO, Onyx Pharmaceuticals
He has served as President, Chief Executive Officer and Director of
the company since 1993. Prior to joining Onyx, Mr. Renton was the
President and Chief Operating Officer of Chiron Corporation.
Harold E. Varmus and J. Michael Bishop
Co-recipients of the 1989 Nobel Prize in Physiology or Medicine for
their discovery of the cellular origins of retroviral oncogenes. They
directed the research that led to the discovery of proto-oncogenes --
normal genes that can be converted to cancer genes by genetic damage.
This work eventually led to the recognition that all cancer probably
arises from damage to normal genes, and provided new strategies for
the detection and treatment of cancer.
Director of the National Human Genome Research Institute (NHGRI) at
the National Institutes of Health (NIH). He led the successful effort
to complete Human Genome Project (HGP), a complex multidisciplinary
scientific enterprise directed at mapping and sequencing all the human
DNA, and determining aspects of its function.
Dr. Ferrara and his team of scientists at Genentech Inc. made a
groundbreaking discovery that added greatly to our understanding and
treatment of cancer. It was the identification and cloning of a gene
termed vascular endothelial growth factor, or VEG
|SOURCE Burrill & Company|
Copyright©2007 PR Newswire.
All rights reserved